Lead inhibits in vitro creatine kinase and pyruvate kinase activity in brain cortex of rats

Toxicology in Vitro

Volumn 24, Issue 3, 2010, Pages 1045-1051

  Lepper, Tatiana Wannmacher ^b   Oliveira, Evandro ^a   Koch, Gustavo Duarte Waltereith ^b   Berlese, Daiane Bolzan ^a   Feksa, Luciane Rosa ^a,b  

^a UNIVERSIDADE FEEVALE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Brain; Creatine kinase; Gluthatione and cysteamine; Lead; Pyruvate kinase

Indexed keywords

CREATINE KINASE; GLUTATHIONE; LEAD; MERCAPTAMINE; PYRUVATE KINASE;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN TOXICITY; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; LEAD POISONING; MALE; NONHUMAN; RAT;

ANIMALS; CEREBRAL CORTEX; CREATINE KINASE; CYSTEAMINE; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLUTATHIONE; LEAD; LEAD POISONING, NERVOUS SYSTEM; MALE; MITOCHONDRIA; PROTECTIVE AGENTS; PYRUVATE KINASE; RATS; RATS, WISTAR; SUBCELLULAR FRACTIONS; SULFHYDRYL COMPOUNDS;

RATTUS;

EID: 77649184035     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2009.11.012     Document Type: Article

References (80)

1. Anderson O. Principles and recent developments in chelation treatment of metal intoxication. Chemical Reviews 99 (1999) 2683-2710
2. Andreoli S.P. Captopril scavenges hydrogen peroxide and reduces, but does not eliminate, oxidant-induced cell injury. American Journal of Physiology 264 (1993) 120-127
3. Armstrong J.S., and Jones D.P. Glutathione depletion enforces the mitochondrial permeability transition and causes cell death in Bcl-2 overexpressing HL60 cells. Journal of the Federation of American Societies for Experimental Biology 16 10 (2002) 1263-1265
4. Aruoma O.I., Akanmu D., Cecchini R., and Halliwell B. Evaluation of the ability of the angiotensin-converting enzyme inhibitor captopril to scavenge reactive oxygen species. Chemico-Biological Interactions 77 (1991) 303-314
5. Bagchi D., Prasad R., and Das D.K. Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor. Biochemical and Biophysical Research Communications 158 (1989) 52-57
6. Bartosz M., Kedziora J., and Bartosz G. Antioxidant and prooxidant properties of captopril and enalapril. Free Radical Biology and Medicine 23 (1997) 729-735
7. Bechara E.J. Oxidative stress in acute intermittent porphyria and lead poisoning may be triggered by 5-aminolevulinic acid. Brazilian Journal of Medical and Biological Research 29 7 (1996) 841-851
8. Benzi G., and Moretti A. Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radical Biology and Medicine 19 (1995) 77-101
9. Bernard A., and Lauwerys R. Metal-induced alterations of delta-aminolevulinic acid dehydratase. Annals of the New York Academy of Sciences 514 (1987) 41-47
10. Berry E.V., and Toms N.J. Pyruvate and oxaloacetate limit zinc-induced oxidative HT-22 neuronal cell injury. Neurotoxicology 27 6 (2006) 1043-1051
11. Bressler J., Kim K.A., and Chakraborti T. Goldstein G. Molecular mechanisms of lead neurotoxicity. Neurochemical Research 24 (1999) 595-600
12. Burlacu A., Jinga V., Gafencu A.V., and Simionescu M. Severity of oxidative stress generates different mechanisms of endothelial cell death. Cell and Tissue Research 306 (2001) 409-416
13. Calderón-Salinas J.V., Hernández-Luna C., Valdez-Anaya B., Maldonado-Vega M., and López-Miranda A. Evolution of lead toxicity in a population of children. Human and Experimental Toxicology 15 (1996) 376-382
14. Calderón-Salinas J.V., Valdez-Anaya B., Mazúñiga-Charles, and Albores-Medina A. Lead exposure in a population of Mexican children. Human and Experimental Toxicology 15 (1996) 305-311
15. Chavez E., Zazueta C., Osornio A., Holguin J.A., and Miranda M.E. Protective behavioral of captopril on Hg++ induced toxicity on kidney mitochondria in vivo and in vitro experiments. Journal of Pharmacology and Experimental Therapeutics 256 (1991) 385-390
16. Chiba M., Shinohara A., Matsushita K., Watanabe H., and Inaba Y. Indices of lead-exposure in blood and urine of lead-exposed workers and concentrations of major and trace elements and activities of SOD GSH-Px and catalase in their blood. Tohoku. Journal of Experimental Medicine 178 (1996) 49-62
17. Christie G.L., Hughes M.A., Rees S.B., and Williams D.R. The binding of metal ions by captopril (SQ 14225) II: complexation of copper(II). Inorganica Chimica Acta 151 (1988) 215-225
18. Cory-Slechta D.A. Lead-induced impairments in complex cognitive function: offerings from experimental studies. Neuropsychology Development Cognitive, Section C, Child Neuropsychology 9 (2003) 54-75
19. Das U.N. Pyruvate is an endogenous anti-inflammatory and anti-oxidant molecule. Medical Science Monitor 12 (2006) 79-84
20. Dominy J.E., Simmons C.R., Hirschberger L.L., Hwang J., Coloso R.M., and Stipanuk M.H. Discovery and characterization of a second mammalian thiol dioxygenase: cysteamine dioxygenase. Journal of Biological Chemistry 282 35 (2007) 25189-25198
21. Flora S.J.S., Bhattacharya R., and Vijayaraghavan R. Combined therapeutic potential of meso 2,3-dimercaptosuccinic acid and calcium disodium edetate in the mobilization and distribution of lead in experimental lead intoxication in rats. Fundamental and Applied Toxicology 25 (1995) 233-240
22. Flora S.J.S., Pande M., and Mehta A. Beneficial effects of combined administration of some naturally occurring antioxidants (vitamins) and thiol chelators in the treatment of lead intoxication. Chemico-Biological Interactions 145 (2003) 267-280
23. Flora S.J.S., Pande M., Kannan G.M., and Mehta A. Lead induced oxidative stress and its recovery following co-administration of melatonin or n-acetylcysteine during chelation with succimer in male rats. Cell and Molecular Biological 50 (2004) 543-551
24. Flora S.J.S., Saxena G., and Mehta A. Reversal of lead induced neuronal apoptosis by chelation treatment in rats: role of ROS and Ca2+. Journal of Pharmacology and Experimental Therapeutics 322 (2007) 108-116
25. Flora S.J.S., Saxena G., Gautam P., Kaur P., and Gill K.D. Lead induced oxidative stress and alterations in biogenic amines in different rat brain regions and their response to combined administration of DMSA and MiADMSA. Chemico-Biological Interactions 170 (2007) 209-220
26. Flora S.J.S., Mittal M., and Mehta A. Heavy metal induced oxidative stress and its possible reversal by chelation therapy. Indian Journal of Medical Research 128 (2008) 221-243
27. Gahl W.A. Early oral cysteamine therapy for nephropathic cystinosis. European Journal of Pediatrics 162 1 (2003) 38-41
28. Garcia-Fernandez A., Bayoumi A.E., Perez-Pertejo Y., Motas M., Reguera P.R.M., Ordonez C., Balana-Fouce R., and Ordonez D. Alterations of the glutathione-redox balance induced by metals in CHO-K1 cells. Comparative Biochemistry and Physiology 132 (2002) 365-373
29. Garza A., Vega R., and Soto E. Cellular mechanisms of lead neurotoxicity. Medical Science Monitor 12 (2006) 57-65
30. Gilbert H.F. Redox control of enzyme activities by thiol/disulfide exchange. Methods in Enzymology 107 (1984) 330-351
31. Goering P.L. Lead-protein interactions as a basis for lead toxicity. Neurotoxicology 14 (1993) 45-60
32. Greenwood N.N., and Earnshaw A. Chemistry of the Elements. second ed. (1997), Butterworth-Heinemann, London
33. Guimarães C.A., and Linden R. Programmed cell death: apoptosis and alternative deathstyles. European Journal of Biochemistry 271 (2004) 1638-1650
34. Gurer H., and Ercal N. Can antioxidants be beneficial in the treatment of lead poisoning?. Free Radical Biology and Medicine 29 10 (2000) 927-945
35. Gurer H., Neal R., Yang P., Oztezcan S., and Ercal N. Captropril as an antioxidant in lead-exposed Fischer 344 rats. Human and Experimental Toxicology 18 (1999) 27-32
36. Gurer-Ohrnan H., Sabir H.U., and Ozgünes H. Correlation between clinical indicators of lead poisoning and oxidative stress parameters in controls and lead-exposed workers. Toxicology 195 (2004) 147-154
37. Hall E.R., and Cottam G.L. Isoenzymes of pyruvate kinase in vertebrates: their physical, chemical, kinetic and immunological properties. International Journal of Biochemistry and Cell Biology 9 (1978) 785-793
38. Hatano E., Tanaka A., Kanazawa A., Tsuyuki S., Tsunekawa S., Iwata S., Ellerby L.M., Bredesen D., Freeze H., Abrahamson M., Bromme D., Krajewski S., Reed J.C., Yin X.M., and Turk V. Inhibition of tumor necrosis factor-induced apoptosis in transgenic mouse liver expressing creatine kinase. Liver International 24 (2004) 384-393
39. Heales S.J., Davis S.E., Bates T.E., and Clark J.B. Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration. Neurochemistry Research 20 (1995) 31-38
40. Hermes-Lima M., Valle V.G.R., Vercesi A.E., and Bechara E.J.H. Damage to rat liver mitochondria promoted by delta-aminolevulinicent porphyria and lead poisoning may be triggered by 5-aminolevulinic acid. Brazilian Journal of Medical and Biological Research 29 (1991) 841-851
41. Holtzman D., DeVries C., Nguyen H., Olson J., and Bensch K. Maturation of resistance to lead encephalopathy: cellular and subcellular mechanisms. Neurotoxicology 5 (1984) 97-124
42. Huang M., Krepkiy D., Hu W., and Petering D.H. Zn-, Cd-, and Pb-transcription factor IIIA: properties, DNA binding, and comparison with TFIIIAfinger 3 metal complexes. Journal of Inorganic Biochemistry 98 (2004) 775-785
43. Hughes B.P. A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clinica Chimica Acta 7 (1962) 597-603
44. Ito Y., Niiya Y., Kurita H., Shima S., and Sarai S. Serum lipid peroxide level and blood superoxide dismutase activity in workers with occupational exposure to lead. International Archives of Occupational and Environmental Health 56 (1985) 119-127
45. Jorgensen F.M. Succimer: the first approved oral lead chelator. American Family Physician 48 (1993) 1496-1502
46. Kalia K., and Flora S.J.S. Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning. Journal of Occupational Health 47 (2005) 1-21
47. Koegh J.P., Steffen B., and Siegers C.P. Cytotoxicity of heavy metals in human small intestinal epithelial cell line I-407: role of glutathione. Journal of Toxicology and Environmental Health 43 (1994) 351-359
48. Korsrud G.O., and Meldrum J.B. Effect of diet on response in rats to lead acetate given orally or in the drinking water. Biological Trace Element Research 17 (1988) 167-173
49. Leong S.F., Lai J.C., Lim L., and Clark J.B. Energy-metabolising enzymes in brain regions of adult and aging rats. Journal of Neurochemistry 37 (1981) 1548-1556
50. Lidsky T.I., and Schneider J.S. Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain Journal of Neurology 126 (2003) 5-19
51. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
52. Mateo R., Beyer W.N., Spann J.W., Hoffman D.J., and Ramis A. Relationship between oxidative stress, pathology, and behavioral signs of lead poisoning in mallards. Journal of Toxicology and Environmental Health 66 (2003) 371-389
53. McGowan C., and Donaldson W.E. Changes in organ nonprotein sulfhydryl and glutathione concentrations during acute and chronic administration of inorganic lead to chicks. Biological Trace Element Research 10 (1986) 37-46
54. Meister A. Glutathione, ascorbate, and cellular protection. Cancer Research 54 (1994) 1969-1975
55. Mishra D., Mehta A., and Flora S.J.S. Reversal of arsenic induced hepatic apoptosis with combined administration of DMSA and its analogue in guinea pigs: role of glutathione and linked enzymes. Chemical Research Toxicology 21 (2008) 400-407
56. Neal R., Yang P., Fiecht J., Yildiz D., Gurer H., and Ercal N. Pro-oxidant effects of delta-aminolevulinic acid on Chinese Hamster Ovary cells. Toxicology Letters 91 (1998) 169-178
57. 2+ on choline acetyltransferase activity from E. electricus (L.) electrocytes: the protective effect of 2,3 dimercapto-propanol (BAL). Medical Science Monitor 11 4 (2005) 100-105
58. Pachauri V., Saxena G., Mehta A., Mishra D., and Flora S.J.S. Combinational chelation therapy abrogates lead-induced neurodegeneration in rats. Toxicology and Applied Pharmacology 240 (2009) 255-264
59. Pande M., and Flora S.J.S. Lead induced oxidative damage and its response to combined administration of α-lipoic acid and succimers in rats. Toxicology 177 (2002) 187-196
60. Penugonda S., Mare S., Lutz P., Banks W.A., and Ercal N. Potentiation of lead-induced cell death in PC12 cells by glutamate: protection by N-acetylcysteine amide (NACA), a novel thiol antioxidant. Toxicology and Applied Pharmacology 216 (2006) 197-205
61. 2+ homeostasis. Neuroscience Research 37 (2000) 227-236
62. Pisoni R.L., Park G.Y., and Velilla V.Q. Detection and characterization of a transport system mediating cysteamine entry into human fibroblast lysosomes. Specificity for aminoethylthiol and aminoethylsulfide derivatives. Journal of Biological Chemistry 270 3 (1995) 1179-1184
63. Qian Y., Falahatpisheh M.H., Zheng Y., Ramos K.S., and Tiffany-Castiglioni E. Induction of 78 kD glucose-regulated protein (GRP78) expression and redox-regulated transcription factor activity by lead and mercury in C6 rat glioma cells. Neurotoxicity Research 3 (2001) 581-589
64. Quintanar-Escorza M.A., González-Martínez M.T., Navarro L., Maldonado M., Arévalo B., and Calderón-Salinas J.V. Intracellular free calcium concentration and calcium transport in human erythrocytes of lead-exposed workers. Toxicology and Applied Pharmacology 220 (2007) 1-8
65. Reed D.J. Glutathione: toxicological implications. Annual Review of Pharmacology and Toxicology 30 (1990) 603-631
66. Reguli J., and Misik V. Superoxide scavenging by thiol/copper complex of captopril an epr spectroscopy study. Free Radical Research 22 (1995) 123-130
67. Salvador R.A., Davison C., and Smith P.K. Metabolism of cysteamine. Journal Pharmacology and Experimental Therapeutics 121 2 (1957) 258-265
68. Savolainen K.M., Loikkanen J., and Naarala J. Amplification of glutamate-induced oxidative stress. Toxicology Letters 82-83 (1995) 399-405
69. Saxena G., and Flora S.J.S. Lead induced oxidative stress and hematological alterations and their response to combined administration of calcium disodium EDTA with a thiol chelator in rats. Journal of Biochemical and Molecular Toxicology 18 (2004) 221-233
70. Saxena G., and Flora S.J.S. Changes in brain biogenic amines and heme-biosynthesis and their response to combined administration of succimers and Centella asiatica in lead poisoned rats. Journal of Pharmacy and Pharmacology 58 (2006) 547-559
71. Schulze A. Creatine deficiency syndromes. Molecular and Cellular Biochemistry 244 (2003) 143-150
72. Scott R.B., Reddy K.S., Husain K., Schlorff E.C., Rybak L.P., and Somani S.M. Dose response of ethanol on antioxidant defense system of liver, lung, and kidney in rat. Pathophysiology 7 (2000) 25-32
73. Struzynska L., Chalimoniuk M., and Sulkowski G. Changes in expression of neuronal and glial glutamate transporters in lead-exposed adult rat brain. Neurochemistry International 47 (2005) 326-333
74. Thoene J.G., Oshima R.G., and Crawhall J.C. Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo. Journal of Clinical Investigation 58 1 (1976) 180-189
75. Valko M., Morris H., and Cronin M.T.D. Metals, toxicity and oxidative stress. Current Medicinal Chemistry 12 (2005) 1161-1208
76. Valle B.L., and Ulmer D.D. Biochemical effects of mercury, cadmium and lead. Annual Review of Biochemistry 41 (1972) 91-128
77. Wakefield J. The lead effect?. Environmental Health Perspectives 110 (2002) 574-580
78. Walliman T., Wyss M., and Brdiczka D. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the phosphocreatine circuit for cellular energy homeostasis. Biochemical Journal 281 (1992) 21-40
79. Westlin W., and Mullane K. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?. Circulation 188 (1988) 130-139
80. Wu G., Fang Y.Z., Yang S., Lupton J.R., and Turner N.D. Glutathione metabolism and its implications for health. Journal of Nutrition 134 (2004) 489-492